BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2177110)

  • 21. Systems biology approaches for toxicology.
    Slikker W; Paule MG; Wright LK; Patterson TA; Wang C
    J Appl Toxicol; 2007; 27(3):201-17. PubMed ID: 17265419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NMDA-receptor-mediated sensory responses of brain noradrenergic neurons are suppressed by in vivo concentrations of extracellular magnesium.
    Shiekhattar R; Aston-Jones G
    Synapse; 1992 Feb; 10(2):103-9. PubMed ID: 1533954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Xenon reduces N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor-mediated synaptic transmission in the amygdala.
    Haseneder R; Kratzer S; Kochs E; Eckle VS; Zieglgänsberger W; Rammes G
    Anesthesiology; 2008 Dec; 109(6):998-1006. PubMed ID: 19034096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and photochemistry of a photolabile precursor of N-methyl-D-aspartate (NMDA) that is photolyzed in the microsecond time region and is suitable for chemical kinetic investigations of the NMDA receptor.
    Gee KR; Niu L; Schaper K; Jayaraman V; Hess GP
    Biochemistry; 1999 Mar; 38(10):3140-7. PubMed ID: 10074369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Excitatory amino acid neurotransmission, excitotoxicity and excitotoxins.
    Shaw PJ
    Curr Opin Neurol Neurosurg; 1992 Jun; 5(3):383-90. PubMed ID: 1320437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deletion of the C-terminal domain of the NR2B subunit alters channel properties and synaptic targeting of N-methyl-D-aspartate receptors in nascent neocortical synapses.
    Mohrmann R; Köhr G; Hatt H; Sprengel R; Gottmann K
    J Neurosci Res; 2002 May; 68(3):265-75. PubMed ID: 12111856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic intermittent ethanol exposure enhances NMDA-receptor-mediated synaptic responses and NMDA receptor expression in hippocampal CA1 region.
    Nelson TE; Ur CL; Gruol DL
    Brain Res; 2005 Jun; 1048(1-2):69-79. PubMed ID: 15919065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excitatory amino acid receptors and disease.
    Meldrum BS
    Curr Opin Neurol Neurosurg; 1992 Aug; 5(4):508-13. PubMed ID: 1325224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Excitatory amino acid receptors, excitotoxicity, and the human nervous system.
    Shaw PJ
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):414-22. PubMed ID: 8389622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synaptic physiology of excitatory amino acids.
    Herrling PL
    Arzneimittelforschung; 1992 Feb; 42(2A):202-8. PubMed ID: 1586392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excitotoxic cell death.
    Choi DW
    J Neurobiol; 1992 Nov; 23(9):1261-76. PubMed ID: 1361523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development.
    McDonald JW; Johnston MV
    Brain Res Brain Res Rev; 1990; 15(1):41-70. PubMed ID: 2163714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Excitatory amino acids in the developing brain: ontogeny, plasticity, and excitotoxicity.
    Hattori H; Wasterlain CG
    Pediatr Neurol; 1990; 6(4):219-28. PubMed ID: 2169749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Amino acids--the most common mediators in the brain].
    Saransaari P; Oja SS
    Duodecim; 1990; 106(22):1556-64. PubMed ID: 1364687
    [No Abstract]   [Full Text] [Related]  

  • 35. Excitatory amino acids in health and disease.
    Thomas RJ
    J Am Geriatr Soc; 1995 Nov; 43(11):1279-89. PubMed ID: 7594165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of excitatory amino acids in synaptic transmission in the hippocampus.
    Lambert JD; Jones RS; Andreasen M; Jensen MS; Heinemann U
    Comp Biochem Physiol A Comp Physiol; 1989; 93(1):195-201. PubMed ID: 2568222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Excitatory amino acid receptors: a gallery of new targets for pharmacological intervention.
    Cunningham MD; Ferkany JW; Enna SJ
    Life Sci; 1994; 54(3):135-48. PubMed ID: 8289575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Slow non-NMDA receptor mediated neurotoxicity and amyotrophic lateral sclerosis.
    Weiss JH; Choi DW
    Adv Neurol; 1991; 56():311-8. PubMed ID: 1649543
    [No Abstract]   [Full Text] [Related]  

  • 39. Interactions between NMDA and dopamine receptors: a potential therapeutic target.
    Wang M; Wong AH; Liu F
    Brain Res; 2012 Oct; 1476():154-63. PubMed ID: 22472597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Excitatory amino acid receptors of cerebellar Purkinje cells: development and plasticity.
    Crepel F; Audinat E
    Prog Biophys Mol Biol; 1991; 55(1):31-46. PubMed ID: 1647540
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.